If you are wondering where your order is, this may answer the question.  BD

High demand for Merck's Zostavax shingles vaccine is causing shortages across the country. Doctors are putting patients on waiting lists; some physicians report hundreds of people in line for the shot. And this despite the fact that the vaccine is approved just for patients 60-plus (Merck is testing it now for the 50- to 59-year-olds)

Patients clamor for scarce Merck vaccine - FiercePharma

1 comments :

  1. Nice blog! There are very few blogs like you, which are so useful and very informative. I like your text. I have a blog on my medical supplies business and came across your blog while researching over Internet.

    ReplyDelete

 
Top
Google Analytics Alternative